Smith & Nephew turns attention to emerging economies to counteract tough European market (The Independent)
Olivier Bohuon, the new CEO of the FTSE 100 medical technology giant Smith & Nephew, will announce plans to grow the business in emerging markets next month.
Mr Bohuon has been reviewing Smith & Nephew's strategy since he succeeded Dave Illingworth in April. It is understood that he wants to stamp his mark on the group by emphasising sales opportunities in fast-growing countries, such as China, where the group has a small presence relative to its other operations.
A...
